Market Tracker

09/23 5:16pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

2.73
Delayed Data
As of Sep 23
 -0.14 / -4.88%
Today’s Change
1.08
Today|||52-Week Range
3.25
+66.46%
Year-to-Date

Today’s Trading

Previous close2.87
Today’s open2.80
Day’s range2.60 - 2.85
Volume1,892,523
Average volume (3 months)299,076
Market cap$79.9M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+9.85%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.50

Competitors

 Today’s
change
Today’s
% change
VRMLVermillion Inc+0.04+3.03%
CALACalithera Bioscience...-0.18-5.66%
INISInternational Isotop...+0.00+2.35%
TRILTrillium Therapeutic...+1.33+9.07%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts